Business

Photo

Wall St. boosted by earnings; on track for best week of year

NEW YORK - U.S. stocks advanced on Friday, as earnings from Microsoft and Procter & Gamble coupled with easing concerns over the possible spread of Ebola in the United States helped put the S&P on track to snap a four-week losing skid.

Recent Business News

P&G to exit Duracell battery business; quarterly sales dip

- Procter & Gamble Co on Friday said it would sell its Duracell battery business, probably through a split-off into a separate company, as it looks to focus on faster-growing brands.

1:38pm EDT

25 European banks set to fail health checks: sources

FRANKFURT - A group of 25 banks have failed European health checks, while up to 10 of those continue to have a capital shortfall, two people familiar with the matter said on Friday, providing a snapshot of the health of the region's lenders.

12:20pm EDT

Deutsche Bank braces for $1.3 billion in U.S., UK Libor fines: sources

FRANKFURT - Deutsche Bank is bracing to pay almost 1 billion euros ($1.3 billion) for Libor-related fines as it nears a deal with U.S. and UK authorities to settle allegations it attempted to manipulate the benchmark interest rate, two sources familiar with the matter said on Friday.

Ex-Bank of New York Mellon trader pleads guilty to insider trading

NEW YORK - A former Bank of New York Mellon Corp trader on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers.

UPS may hike charges for major customers for holiday package surges

CHICAGO - United Parcel Service Inc may charge major customers more for a surge in late, unplanned packages or turn down the business if it threatens disruptions during the peak holiday season, a top executive said on Friday, trying to avoid a repeat of last year's delivery meltdown.

11:41am EDT

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Big Pharma’s race to develop an Ebola vaccine

the World Health Organization made real news this week as it announced large-scale clinical trials, due to start in January, 2015, in the rush to vaccinate against the further spread of Ebola in West Africa.